Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Hu, Yali ^a   Zhang, Shu ^a   Luo, Chao ^a   Liu, Qilan ^b   Zhou, Yi Hua ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b Jiangsu Family Planning Institute   (China)

Author keywords

Gaps; Hepatitis B virus; Immunoprophylaxis; Perinatal infection

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; ARTICLE; CHINA; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; INFANT; MALE; MATERNAL BLOOD; NEWBORN; POPULATION RESEARCH; PREGNANT WOMAN; PRENATAL SCREENING; PREVALENCE; RURAL POPULATION; VERTICAL TRANSMISSION; VIRUS CARRIER; VIRUS TRANSMISSION;

ADULT; CHEMOPREVENTION; CHINA; COMMUNICABLE DISEASE CONTROL; ENDEMIC DISEASES; FEMALE; GUIDELINE ADHERENCE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84866143701     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-221     Document Type: Article

References (25)

1. Mahamat A, Louvel D, Vaz T, Demar M, Nacher M, Djossou F. High prevalence of HBsAg during pregnancy in Asian communities at Cayenne Hospital, French Guiana. Am J Trop Med Hyg 2010, 83:711-713. 10.4269/ajtmh.2010.09-0727, 2929075, 20810844.
2. Rein DB, Lesesne SB, Leese PJ, Weinbaum CM. Community-based hepatitis B screening programs in the United States in 2008. J Viral Hepat 2010, 17:28-33. 10.1111/j.1365-2893.2009.01165.x, 19674286.
3. McMahon BJ, Bulkow LR, Singleton RJ, Williams J, Snowball M, Homan C, Parkinson AJ. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 2011, 54:801-807. 10.1002/hep.24442, 21618565.
4. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, Kao JH, Lin YC, Chen HL, Hsu HY, Chen DS. Two decades of universal hepatitis B vaccination in Taiwan, impact and implication for future strategies. Gastroenterology 2007, 132:1287-1293. 10.1053/j.gastro.2007.02.055, 17433322.
5. Chen DS. Hepatitis B vaccination, The key towards elimination and eradication of hepatitis B. J Hepatol 2009, 50:805-816. 10.1016/j.jhep.2009.01.002, 19231008.
6. World Health Organization Hepatitis B vaccines. Wkly Epidemiol Rec 2009, 84:405-420. World Health Organization.
7. Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B, the Chinese experience. Chin Med J (Engl) 2009, 122:98-102.
8. Lu FM, Zhuang H. Prevention of hepatitis B in China, achievements and challenges. Chin Med J (Engl) 2009, 122:2925-2927.
9. Heininger U, Vaudaux B, Nidecker M, Pfister RE, Posfay-Barbe KM, Bachofner M, Hoigne I, Gnehm HE. Evaluation of the compliance with recommended procedures in newborns exposed to HBsAg-positive mothers, a multicenter collaborative study. Pediatr Infect Dis J 2010, 29:248-250. 10.1097/INF.0b013e3181bd7f89, 19935120.
10. Plitt SS, Somily AM, Singh AE. Outcomes from a Canadian public health prenatal screening program for hepatitis B, 1997-2004. Can J Public Health 2007, 98:194-197.
11. Bracciale L, Fabbiani M, Sansoni A, Luzzi L, Bernini L, Zanelli G. Impact of hepatitis B vaccination in children born to HBsAg-positive mothers, a 20-year retrospective study. Infection 2009, 37:340-343. 10.1007/s15010-008-8252-3, 19629385.
12. Stroffolini T, Bianco E, Szklo A, Bernacchia R, Bove C, Colucci M, Cristina Coppola R, D'Argenio P, Lopalco P, Parlato A, Ragni P, Simonetti A, Zotti C, Mele A. Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy. Vaccine 2003, 21:1246-1249. 10.1016/S0264-410X(02)00439-5, 12559805.
13. Zhou J, Hu Y, Liu Q, Chen Q, Xu B, . The Group of Birth Defects Intervention Project in Jiangsu Province Analysis of birth defects based on population survey in Jiangsu Province. Jiangsu Medical Journal 2007, 33:1218-1220. in Chinese, The Group of Birth Defects Intervention Project in Jiangsu Province.
14. Zhang S, Li RT, Wang Y, Liu Q, Zhou YH, Hu Y. Seroprevalence of hepatitis B surface antigen among pregnant women in Jiangsu, China, 17 years after introduction of hepatitis B vaccine. Int J Gynaecol Obstet 2010, 109:194-197. 10.1016/j.ijgo.2010.01.002, 20152977.
15. Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, Maley MW, Ayres A, Locarnini SA, Levy MT. Perinatal transmission of hepatitis B virus, an Australian experience. Med J Aust 2009, 190:489-492.
16. Song YM, Sung J, Yang S, Choe YH, Chang YS, Park WS. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr 2007, 166:813-818. 10.1007/s00431-006-0327-5, 17120036.
17. Utsumi T, Yano Y, Lusida MI, Amin M, Soetjipto, Hotta H, Hayashi Y. Serologic and molecular characteristics of hepatitis B virus among school children in East Java, Indonesia. Am J Trop Med Hyg 2010, 83:189-193. 10.4269/ajtmh.2010.09-0589, 2912598, 20595500.
18. Motta-Castro AR, Gomes SA, Yoshida CF, Miguel JC, Teles SA, Martins RM. Compliance with and response to hepatitis B vaccination in remaining quilombo communities in Central Brazil. Cad Saude Publica 2009, 25:738-742. 10.1590/S0102-311X2009000400004, 19347199.
19. Bascom S, Miller S, Greenblatt J. Assessment of perinatal hepatitis B and rubella prevention in New Hampshire delivery hospitals. Pediatrics 2005, 115:e594-e599. 10.1542/peds.2004-2057, 15867025.
20. Liu CY, Chang NT, Chou P. Seroprevalence of HBV in immigrant pregnant women and coverage of HBIG vaccine for neonates born to chronically infected immigrant mothers in Hsin-Chu County, Taiwan. Vaccine 2007, 25:7706-7710. 10.1016/j.vaccine.2007.07.056, 17767981.
21. Papaevangelou V, Hadjichristodoulou C, Cassimos D, Theodoridou M. Adherence to the screening program for HBV infection in pregnant women delivering in Greece. BMC Infect Dis 2006, 6:84. 10.1186/1471-2334-6-84, 1475591, 16681862.
22. Spada E, Tosti ME, Zuccaro O, Stroffolini T, Mele A, . Collaborating Study Group Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy. J Infect 2011, 62:165-171. 10.1016/j.jinf.2010.11.014, 21129400, Collaborating Study Group.
23. Willis BC, Wortley P, Wang SA, Jacques-Carroll L, Zhang F. Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus. Pediatrics 2010, 125:704-711. 10.1542/peds.2009-1831, 20211952.
24. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B, special emphasis on disease progression and prognostic factors. J Hepatol 2008, 48:335-352. 10.1016/j.jhep.2007.11.011, 18096267.
25. Chen CY, Hsu HY, Liu CC, Chang MH, Ni YH. Stable seroepidemiology of hepatitis B after universal immunization in Taiwan, A 3-year study of national surveillance of primary school students. Vaccine 2010, 28:5605-5608. 10.1016/j.vaccine.2010.06.029, 20598405.